Gut bacteria therapy reduces serious infections in stem cell patients

A trial testing oral formulations of beneficial microbes showed a notable reduction in dangerous bloodstream infections among stem cell transplant recipients. Patients taking the experimental treatment also required fewer days of systemic antibiotic administration.